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Should Kiribati continue to aim for 100% voluntary non- 
remunerated blood donation as recommended by the WHO?
G. Tauma,1 A. D. Harries,2,3 O. E. A. Merilles, Jr,4 R. Tekoaua,1 B. Teriboriki1
Blood transfusion can save lives and improve health. Transfusions are mainly used for surgery, 
trauma, pregnancy-related complications, haemato-
logical malignancies and childhood anaemia caused 
by a variety of different conditions. Many patients re-
quiring transfusion do not have timely access to safe 
blood; this unavailability has led to deaths and to pa-
tients suffering from ill health.1
All countries need to ensure that their blood sup-
plies are sufficient and free from the human immuno-
deficiency virus (HIV), hepatitis viruses and other infec-
tions that can be transmitted through transfusion. An 
adequate, reliable supply of safe blood can only be as-
sured through a stable base of regular voluntary and 
unpaid donors, as this group has the lowest prevalence 
of blood-borne infections.1 In 2009 and 2010, the 
World Health Organization (WHO) and various inter-
ested stakeholders and experts recommended that all 
countries should strive for 100% voluntary blood dona-
tion by 2020 and that family replacement and paid 
blood donation should be phased out by this date.2,3 By 
2012, however, 72 countries were still obtaining less 
than 50% of their blood supplies from voluntary un-
paid donors, with much of the blood supply still depen-
dent on family replacement and paid blood donors.1
Kiribati, an island country in the Central and 
North-East Pacific, has three main hospitals where 
blood transfusion services are located. All potential 
blood donors are screened through an algorithmic ap-
proach (see Setting), and may be deferred (i.e., not al-
lowed to donate blood) at each step.
For many years, the blood transfusion services in 
Kiribati have mainly relied on family replacement do-
nors (FRD), resulting in a significant proportion of do-
nors being deferred. In 2009, the WHO led a global 
consultation urging countries to adopt 100% volun-
tary non-remunerated blood donation.4 A large num-
ber of countries participated in this consultation, in-
cluding Kiribati, which signed the Melbourne 
Declaration.3 A National Blood Policy was developed, 
which resulted in changes to the information collected 
about family-based or voluntary blood donation in 
registers and worksheets as well as increased advocacy 
about the importance of voluntary blood donations.
We were therefore interested to find out whether, 
in the last few years, from 2011 to early 2016, there 
were any changes in the number and proportion of 
voluntary non-remunerated blood donors (VNRBD), 
any changes in the number and proportion of defer-
rals and documented reasons for these deferrals. Spe-
cific objectives were to determine 1) the number of 
potential blood donors in each full year from 2011 to 
2015 who were VNRBD or FRD and the number and 
proportion who were deferred; 2) the characteristics of 
all potential blood donors and those who were de-
ferred from January 2011 to March 2016; and 3) the 




This was a retrospective cross-sectional study of poten-
tial blood donors and deferrals between January 2011 
and March 2016 using already collected data.
Setting
General setting
Kiribati is an island republic comprising 33 coral 
atolls, reef islands and one raised coral atoll stretching 
along the equator. It has a total land area of 800 km2 
(310 square miles), with the islands dispersed over 3.5 
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Setting: Tungaru Central Hospital Blood Bank Labora-
tory, Nawerewere, Tarawa, Kiribati.
Objective: To determine characteristics, deferrals and 
reasons for deferral amongst blood donors from 2011 to 
2016.
Design: A cross-sectional study using routinely collected 
data.
Results: From January 2011 to March 2016, 8531 poten-
tial blood donors were registered. For each full year, the 
proportion of voluntary non-remunerated blood donors 
(VNRBD) was below 10%, although it increased to 13% 
in 2015. The overall proportion of blood donors deferred 
increased each year over the 5-year period, from 44% to 
57%, with similar increases in deferrals in VNRBD and 
family replacement donors (FRD). Among all blood do-
nors, a higher proportion of females than males (59% vs. 
43%) and VNRBD than FRD (56% vs. 44%) were de-
ferred (P  0.001). Deferrals were due to 1) failing the 
medical questionnaire (53%), 2) having anaemia and/or 
high white cell count (26%), or 3) transfusion-transmissi-
ble infections (21%). More VNRBD were deferred due to 
failing the medical questionnaire, while more FRD were 
deferred due to anaemia and/or high white-cell count; 
the number of deferrals was similar for transfusion-trans-
missible infections.
Conclusion: This 5-year study showed that the propor-
tion of VNRBD is low and deferrals are higher for this 
group than for FRD. There is a strong case for encourag-
ing both types of donor in the country.
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million km2 (1 351 000 square miles).5 In 2010, Kiribati 
had a total population of 103 058. South Tarawa, the 
capital, had a population of 34 427; the population of 
Line and Phoenix Islands was 5791, and that of Tabi-
teuea North island was 1290.5,6 The population of Kiri-
bati has a life expectancy at birth of 60 years (57 for 
males and 63 for females) and an infant mortality rate 
of 54 deaths per 1000 live births.5 In 2014, the country 
had a gross domestic product of USD 1605 per capita.7
Study setting and blood transfusion services
The National Blood Transfusion Service (NBTS) is an 
integral part of the national health delivery system, 
which operates under the government of Kiribati 
through the Ministry of Health and Medical Services 
(MHMS).8 The NBTS operates through three hospitals 
located on three different islands—South Tarawa, 
Christmas Island and Tabiteuea North Island—and de-
livers transfusion services to the general public. The 
blood transfusion programme is overseen by the Na-
tional Blood Transfusion Committee, and is imple-
mented by various stakeholders within the MHMS 
clinical departments and other government and 
non-government organisations, including the Kiribati 
Red Cross Society (KRCS).
The current study was carried out at the Tungaru 
Central Hospital, situated on the capital island of South 
Tarawa where almost half the total population of Kiri-
bati lives. Potential blood donors either present volun-
tarily to the blood bank, on their own or with notifica-
tion from families, or are actively recruited by the KRCS. 
At the Tungaru Central Hospital Blood Bank Laboratory 
(BBL), all potential blood donors (eligibility criteria are 
ages 18–50 years) undergo a three-step algorithmic 
screening. In the first step, potential blood donors com-
plete a medical questionnaire; any person who ticks any 
of the stated exclusion criteria is deferred (i.e., not al-
lowed to donate blood). The medical questionnaire cri-
teria for deferral are shown in Table 1. In the second 
step, the remaining potential blood donors are tested 
for haemoglobin (Hb) and white blood cell count 
(WBC); anyone with Hb  12.0g/dl or WBC  11.0 × 
109/l is deferred. In the third and final step, the remain-
ing potential blood donors are tested serologically for 
hepatitis B virus (Alere DetermineTM HBsAg, Alere, 
Waltham, MA, USA), hepatitis C virus (SD Bioline HCV 
rapid diagnostic test, Standard Diagnostics Inc, Gyeong-
gi-do, Korea), HIV (Alere DetermineTM HIV-1/2) and 
syphilis (Alere DetermineTM Syphilis TP test). Anyone 
positive for these viruses or bacteria is also deferred.
Potential donors who pass through these three 
steps are accepted for blood donation. The blood is 
grouped and cross-matched, stored at the BBL centre 
and processed in accordance with the BBL standard 
operating procedures.9 Blood donors with Hb  12 g/
dl, WBC  11.0 × 109/l or a positive rapid serological 
test result are deferred from blood transfusion and re-
ferred to the general health services. The potential 
blood donor information and screening results are re-
corded by the blood bank laboratory technician in 
standardised forms, registers, worksheets and an elec-
tronic database and kept at the BBL.
Study population
All potential blood donors registered at Tungaru Cen-
tral Hospital, South Tarawa, Kiribati, between January 
2011 and March 2016 were included in the study.
Data variables, sources of data and data 
collection
Data variables for each potential blood donor included 
year of registration, type of blood donor (FRD, VN-
RBD), age, sex, deferral (and for those who were de-
ferred, the reason), the medical questionnaire criteria, 
blood test results for Hb (test performed, Hb  12 g/
dl), WBC (test performed, WBC  11.0 × 109/l) and 
HBsAg, HCV, HIV and syphilis serology (test per-
formed, positive). The sources of data were the BBL for 
Blood Donor Register(s) 2011–2014, interview forms 
and the electronic database 2015–2016 at Tungaru 
Central Hospital, South Tarawa. Data were collected 
into a paper-based structured spreadsheet.
Analysis and statistics
Data were single-entered into Epi Info Version 7.0 
(Centers for Disease Control and Prevention, Atlanta, 
GA, USA). A descriptive analysis was performed using 
absolute numbers, frequencies and proportions. Char-
acteristics of blood donors who were deferred and 
those not deferred were compared using the χ2 test; 
differences at the 5% level were regarded as 
significant.
Ethics approval
Permission for the study was obtained from the direc-
tor of Tungaru Central Hospital, Tarawa, Kiribati. Eth-
ics approval was obtained from the local Medical 
Council of Kiribati, Tarawa, and the Ethics Advisory 
Group of the International Union Against Tuberculosis 
and Lung Disease, Paris, France. Patient consent was 
not required, as this was secondary data obtained from 
registers and an electronic database.
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TABLE 1 Criteria listed in the medical questionnaire for deferring potential blood donors
Criteria
Previously rejected as a blood donor
In the past 6 months: having sex with more than one sexual partner; having sex with someone the donor is unsure about and/
or having a tattoo or body piercing
Having ever had a sexually transmitted infection
Having any of the following: weight loss (unknown cause); heart disease and/or chest pain; feeling faint or dizzy; persistent 
diarrhoea; abnormal bleeding; any defined blood disorder; diabetes mellitus; any defined kidney disorder; malaria, dengue 
or chikungunya; leprosy
Being pregnant 
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RESULTS
From January 2011 to the end of March 2016, 8531 potential 
blood donors were registered at Tungaru Central Hospital. The 
numbers of potential donors and those who were deferred each 
year from 2011 to 2015, stratified by VNRBD, FRD and type of 
blood donor status unknown, are shown in Table 2. Some of the 
data for 2013 and 2014 were incomplete due to missing registers. 
Despite the incomplete data, the proportion of VNRBD was low 
throughout the 5 years, although in 2015 it increased to 13% of 
all potential blood donors. In the first 2 years, the proportion 
with unknown type of donor status was respectively 28% and 
33%, but this declined, and in 2015 it was 6% of all potential 
blood donors. There was a steady increase in all deferrals from 
2012 to 2015; this was the same for those who were VNRBD and 
FRD. Although there were few donors with no type of donor sta-
tus recorded from 2013 to 2015, the proportion deferred was 
high, ranging from 50% to 89%. 
The characteristics of all potential blood donors and those 
who were deferred during the study period are shown in Table 
3. For sex, age and type of donor, there was a large amount of 
missing data. Where data were available, there was a signifi-
cantly higher proportion of females being deferred (P  
0.001). Similar proportions were deferred between the three 
main eligible age groups. Sixty potential blood donors were ei-
ther too young (age 18 years) or too old (age 50 years) to 
give blood, and 62% of these were deferred. A significantly 
higher proportion of VNRBD than FRD were deferred (P  
0.001).
Reasons for deferral amongst those deferred are shown in 
Table 4. Over 50% were deferred as a result of the initial medical 
questionnaire. Of the 26% who were deferred because of low Hb 
(12.0 g/dl) and/or high WBC (11.0 × 109/l), the reason was 
mainly high WBC. Of the 21% who were deferred because of a 
positive viral or bacterial serological test result, positive HBsAg 
and/or syphilis serology were the predominant causes. Table 5 
shows the different reasons for deferral in VNRBD and FRD. A sig-
nificantly higher proportion of VNRBD were deferred at the first 
step, through the medical questionnaire, and a significantly 
higher proportion of FRD were deferred at the second step, due to 
anaemia and/or high WBC. Both the VNRBD and the FRD defer-
rals were similar with respect to positive viral and/or bacterial se-
rological test results.
DISCUSSION
This is the first study from Kiribati to assess the profile of poten-
tial blood donors, the proportions deferred and the reasons for 
deferral over a 5-year period. There were some important find-
ings. First, although Kiribati agreed to the WHO recommenda-
tions in 2009 to increase the proportion of the VNRBD, this pro-
portion remained low, and, although it increased in 2015, it still 
only reached 13%. It is difficult to find recently published infor-
mation about the rates of VNRBD amongst blood donors from 
other countries. In Egypt, only 12% of a cohort of 17 000 donors 
screened in 2010–2011 were VNRBD.10 In Guangdong Province, 
China, however, where blood donations increased by nearly 40% 
between 2006 and 2014, the proportion of FRD had decreased 
from 40% to 20%.11 We can find no recent information from the 
Pacific region about trends in blood donor status during the last 5 
years to compare with our findings.
TABLE 2 The number of potential blood donors and those deferred* each year at Tungaru Central Hospital, Tarawa, 
Kiribati, 2011–2015, stratified by those who were VNRBD, those who were FRD and those whose type of donor status 
was not recorded











Potential blood donors 1896 1883 1367† 1064† 2314
 Deferred 836 (44) 789 (42) 595 (44) 504 (47) 1321 (57)
Potential blood donors who were FRD 1326 1103 1285 976 1870
 Deferred 461 (35) 448 (41) 543 (42) 449 (46) 995 (53)
Potential blood donors who were VNRBD 35 151 65 70 294
 Deferred 16 (46) 55 (36) 38 (58) 44 (63) 193 (66)
Potential blood donors whose status was not recorded 535 629 19 18 150
 Deferred 359 (67) 286 (45) 14 (74) 9 (50) 133 (89)
* Not allowed to donate blood.
† Some of the registers were missing and the numbers for these 2 years are therefore incomplete.
VNRBD = voluntary non-remunerated blood donors; FRD = family replacement donors.
TABLE 3 Characteristics of all potential blood donors and those 






Potential blood donors 
who were deferred 
n (%)
All blood donors 8531 4050 (47)
Sex
 Male 6717 2873 (43)
 Female 1426 848 (59)
 Not recorded 388 329 (85)
Age, years
 18 25 19 (76)
 18–28 5928 2732 (46)
 29–39 1482 653 (44)
 40–50 522 235 (45)
 >50 35 18 (51)
 Not recorded 539 393 (73)
Type of blood donor
 FRD 6565 2902 (44)
 VNRBD 615 347 (56)
 Status not recorded 1351 801 (59)
* Not allowed to donate blood.
FRD = family replacement donors; VNRBD = voluntary non-remunerated blood 
donors.
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Second, the total number of potential blood donors deferred 
during this 5-year period increased steadily from 2012 to 2015; 
this increase was apparent in both FRD and VNRBD. Moreover, 
when analysing all the blood donors together, there were signifi-
cantly more deferrals in the VNRBD compared with the FRD 
group. A strong reason for advocating for VNRBD is that these do-
nors have a lower prevalence of transfusion-transmissible infec-
tions than FRD,2 so our results may seem surprising. There are, 
however, other reasons for potential blood donors being deferred, 
and in Kiribati these included failing the medical questionnaire 
assessment, being anaemic or having a high WBC. Anaemia 
might be one reason why more females were deferred in our study 
compared with males; this observation has been reported else-
where.12 In our study, a further reason for deferral was that some 
people registering for potential blood donation were in fact not 
eligible due to age restrictions (age 18 years or 50 years).
Third, of those who underwent serological tests for transfu-
sion-transmissible infections, the most common reasons for de-
ferral were being HBsAg-positive and/or positive for syphilis. 
These findings are in line with reports from countries where HIV 
is not endemic.13,14
Finally, there were differences between VNRBD and FRD in rea-
sons for deferral, with more VNRBD deferred due to the medical 
questionnaire and more FRD deferred due to anaemia or high 
WBC. There were no differences with respect to transfusion-trans-
missible infections.
The strengths of this study were the large number of blood 
donors referred from different parts of South Tarawa, an island 
inhabited by half the population of Kiribati, and as such we feel 
that the results are probably representative of blood donor prac-
tices in the country. The conduct and reporting of our study ad-
TABLE 4 Reasons for deferral* amongst all donors deferred at 




 Deferrals due to exclusion criteria in medical 
questionnaire 2145 (53)†
Second step
 Deferrals due to Hb  12.0g/dl and/or  
WBC  11.0 × 109/l 1054 (26)†
 Hb  12.0 g/dl 247‡ (23)§
 WBC  11.0 × 109/l 836‡ (77)§
Third step 
 Deferrals due to positive viral and/or bacterial 
blood test 851 (21)†
 Positive HBsAg serology 633¶ (74)#
 Positive syphilis serology 224¶ (26)#
 Positive HIV serology 5¶ (1)#
 Positive HCV serology 2¶ (1)#
* Not allowed to donate blood.
† Denominator is total number of deferrals (n = 4050)
‡ 29 donors had both Hb  12.0 g/dl and WBC  11.0 × 109/l.
§ Denominator is number of deferrals due to Hb  12.0 g/dl and WBC  11.0 × 
109/l (n = 1083).
¶ 12 donors had both positive HBsAg serology and positive syphilis serology; 1 donor 
had both positive syphilis serology and positive HCV serology.
# Denominator is number of deferrals due to positive viral or bacterial blood test (n = 
864).
Hb = haemoglobin; WBC = white blood cell count; HBsAg = hepatitis B surface anti-
gen; HIV = human immunodeficiency virus; HCV = hepatitis C virus.
TABLE 5 Reasons for deferral* amongst VNRBD and FRD deferred at Tungaru Central Hospital, Tarawa, 
Kiribati, January 2011–March 2016
Characteristics
VNRBD FRD
P valuen (%) n (%)
All deferrals 347 (100) 2902 (100)
First step
 Deferrals due to exclusion criteria in medical questionnaire 223 (64)† 1570 (54)‡ 0.001
Second step
 Deferrals due to Hb  12.0g/dl and/or WBC > 11.0 × 109/l 60 (17)† 745 (26)‡
 Hb  12.0 g/dl 20§ (33) ¶ 192# (25)**
 WBC > 11.0 × 109/l 41§ (67) ¶ 575# (75)** 0.001
Third step
 Deferrals due to positive viral and/or bacterial blood test 64 (19)† 587 (20)‡ 0.43
 Positive HBsAg serology 53 (83)†† 424‡‡ (71)§§
 Positive syphilis serology 11 (17)†† 165‡‡ (28)§§
 Positive HIV serology 0 4 (1)§§
 Positive HCV serology 0 2‡‡ (1)§§
* Not allowed to donate blood.
† Denominator is total number of deferrals (n = 347).
‡ Denominator is total number of deferrals (n = 2902).
§ One donor had both Hb  12.0 g/dl and WBC  11.0 × 109/l.
¶ Denominator is number of deferrals due to HB  12.0 g/dl and WBC  11.0 × 109/l (n = 61).
# 22 donors had both Hb  12.0g/dl and WBC  11.0 × 109/l.
** Denominator is number of deferrals due to HB  12.0 g/dl and WBC  11.0 × 109/l (n = 767).
†† Denominator is number of deferrals due to a positive viral or bacterial blood test (n = 64).
‡‡ One donor had both positive syphilis serology and positive HCV serology; seven donors had both positive syphilis serology and 
positive HBsAg serology.
§§ Denominator is number of deferrals due to a positive viral or bacterial blood test (n = 595).
VNRBD = voluntary non-remunerated blood donors; FRD = family replacement donors; Hb = haemoglobin; WBC = white blood 
cell count; HBsAg = hepatitis B surface antigen; HIV = human immunodeficiency virus; HCV = hepatitis C virus.
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hered to the RECORD guidelines.15 There were some limitations 
related to the operational nature of the study, using routinely 
collected secondary data. There were large numbers of missing 
data for sex, age and type of blood donor status, although this 
had improved by 2015 compared with earlier years. There were 
also registers missing for 2013 and 2014. Finally, we included 
donors who returned on more than one occasion to donate 
blood, as their donation status could change from one visit to 
the next.
There are a number of implications for the blood donation 
practices in Kiribati. First, given the small proportion of VNRBD 
and the fact that deferrals were higher in this group than for FRD, 
there is a case for encouraging both types of donor in Kiribati. A 
recent review provided compelling evidence that VNRBD are no 
safer than FRD and that only repeat donation provides improved 
blood safety.16 Further studies have confirmed that FRD are no 
different from VNRBD, that they may be more directly motivated 
and that they constitute a legitimate and important source for im-
proving blood supplies in resource-poor countries.17,18 Second, 
given the large amount of missing data, especially for blood do-
nor status, there is an important and urgent need to improve doc-
umentation and coding. The system in the Tungaru Central Hos-
pital BBL is now electronic, and the issue of the missing registers 
should not recur. The electronic system needs strengthening, 
however, and reliable data back-up systems are essential. Finally, 
we need to understand more about why half the donors who are 
deferred are excluded at the first step through the medical ques-
tionnaire, and whether donors with high WBC are a potential 
threat for donation.
In conclusion, this 5-year study in Kiribati has shown that de-
spite WHO recommendations, the proportion of VNRBD is low 
and deferrals are higher than among FRD. There is a strong case 
for encouraging both types of donor in the country.
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Contexte  :  Banque du sang de l’hôpital central de Tungaru, Kiribati.
Objectif  :  Déterminer les caractéristiques, exclusions et motifs 
d’exclusion parmi les donneurs de sang de 2011 à 2016.
Schéma  :  Etude transversale basée sur des données recueillies en 
routine.
Résultats  :  Il y avait 8531 donneurs de sang potentiels enregistrés 
entre janvier 2011 et mars 2016. Pour chaque année, la proportion 
de donneurs de sang bénévoles non rémunérés (VNRBD) a été 
inférieure à 10%, en dehors d’une augmentation à 13% en 2015. 
La proportion de donneurs de sang qui ont été exclus a augmenté 
chaque année au cours des 5 années de l’étude, de 44% à 57%, 
avec une augmentation similaire des exclusions chez les VNRBD et 
les donneurs de remplacement familiaux (FRD). Si l’on considère 
l’ensemble des donneurs, une plus grande proportion de femmes 
que d’hommes (59% contre 43%) et de VNRBD comparés aux FRD 
(56% contre 44%) ont été exclus (P  0,001). Les exclusions ont 
été causées par un rejet lié aux réponses au questionnaire médical 
(53%), une anémie et/ou un nombre élevé de globules blancs 
(26%) ou une infection transmissible par la transfusion (21%). 
Davantage de VNRBD ont été refusés à cause du questionnaire 
médical, plus de FRD ont été rejetés à cause d’une anémie et/ou 
d’un nombre de globules blanches trop élevé et les exclusions ont 
été similaires en ce qui concerne les infections transmissibles par 
transfusion.
Conclusion  :  Cette étude sur 5 ans a montré que la proportion de 
VNRBD était faible et que les exclusions y étaient plus fréquents que 
chez les FRD. Il y a là un motif sérieux pour encourager les deux types 
de donneurs dans le pays.
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Marco de referencia: El laboratorio del banco de sangre del Hospital 
Central de Tungaru, en Kiribati.
Objetivo: Determinar las características de los donantes, la 
frecuencia de los aplazamientos y sus razones en las donaciones de 
sangre realizadas del 2011 al 2016.
Método: Un estudio transversal a partir de los datos recogidos en la 
práctica corriente.
Resultados: Se registraron 8531 posibles donantes de sangre de 
enero del 2011 a marzo del 2016. En cada año completo, la 
proporción de donantes de sangre voluntarios no remunerados 
(VNRDB) fue inferior al 10%, pero en el 2015 aumentó al 13%. La 
proporción de donantes aplazados aumentó cada año durante los 5 
años de 44% a 57% y el aumento de los aplazamientos fue equivalente 
en los VNRDB y los donantes familiares o de sustitución (FRD). Al 
considerar todos los donantes de sangre, se observó una mayor 
proporción de aplazamientos de mujeres que de hombres (59% contra 
43%) y de VNRDB que de FRD (56% contra 44%; P  0,001). Las 
causas del aplazamiento fueron el resultado del cuestionario médico 
(53%), la presencia de anemia o leucocitosis (26%) y las infecciones 
transmisibles mediante transfusión (21%). Los VNRDB se aplazaron 
con mayor frecuencia por causa del cuestionario médico y los FRD por 
anemia o leucocitosis; los aplazamientos por riesgo de transmisión de 
infecciones fueron equivalentes en ambos grupos.
Conclusión: El presente estudio de 5 años reveló una baja 
proporción de VNRDB y puso en evidencia que los aplazamientos son 
más frecuentes en este grupo que en los FRD. Existen argumentos 
sólidos que respaldan la promoción de ambos tipos de donantes en 
el país.
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